Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - OTHER CURRENT LIABILITIES
Other Current Liabilities FATE - Fate Therapeutics, Inc.
27.5 M
LAST VALUE
-17.10%
2 YEAR CAGR
16.12%
5 YEAR CAGR
28.82%
10 YEAR CAGR